Atrandi Biosciences is advancing the frontier of single-cell analysis with its proprietary Semi-Permeable Capsule (SPC) technology. The platform encapsulates hundreds of thousands of cells in permeable microenvironments, enabling complex, multi-step reactions at scale while preserving single-cell resolution. By combining throughput with precision, Atrandi unlocks true multiomic insights and accelerates biological discovery. Founded in 2016, Atrandi - meaning “you discover” in Lithuanian -embodies the company’s mission to empower scientists to reveal the complexity of life.
industries
Milestones
Lux investment: 2025
Founders
Linas Mazutis
Juozas Nainys
Karolis Leonavicius
Dalius Kuciauskas
Rapolas Zilionis
Lux partners
David Yang
Shaq Vayda